Peer Insights: Maximizing Myeloma Patient Care
Peer Insights: Maximizing Myeloma Patient Care from Patient Empowerment Network on Vimeo.
Dr. Beth Faiman shares how clinical trials offer vital support for myeloma patients by providing access to a diverse team of healthcare professionals. Despite existing challenges, such as outdated procedures, practice barriers within the hospital organization and scope of practice limitations, Dr. Faiman speaks to the pivotal role of multidisciplinary teams for maximizing myeloma patient care.
Related Resources:
Peer Insights: Fostering Clinic-Wide Engagement for Myeloma Clinical Trials |
How Can Myeloma HCPs and Nurses Help Manage Patient Concerns? |
|
Transcript:
Dr. Beth Faiman:
How can we harness all of our resources to provide the best care to that patient? And clinical trials are one of them. Clinical trials will offer support so that the patient can have access to a pharmacist, a social worker, a dedicated nurse, a dedicated line to call if they’re having a symptom. But to speak to some of the outdated procedures, again, it goes to scope of the practice. No matter how highly trained they are experientially or with credentialing, there are practice barriers within the hospital organization within state laws.
The nice thing about clinical trials though, is that nurses in most institutions are very able to watch that clinical protocol. They’ll look for who needs to hold a medication because of toxicity, consult with the provider, and then they’ll say, “Okay, hold your dose. And when your toxicity resolves, reduce it one dose level, and come back for labs,” or whatever that would entail. So while there are outdated practices historically, I think that within clinical trials nursing it provides some more autonomy for oncology nurses, again, as a part of that multidisciplinary team to enhance patient care.
